drugset / Trial / NCT01543724

Neural Correlates for Therapeutic Mechanisms of Lithium in Bipolar Disorder

NCT01543724

NaSingle-groupOpen-labelBasic science

Summary

The investigators will assess Li-induced gray matter volume changes with regard to the endophenotype of GSK3beta polymorphism. The changes of gray matter are supposed to be more attributable to neurotrophic and neuroprotective characteristics of Li, which were closely related to the inhibition of apoptotic activity of GSK3beta.

Timeline

Start
2015-06-01
Primary completion
2017-12-31
Completion
2017-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Lithium Unknown 10 mg/kg

Indications